 6. Administration of any standard, non-adjuvanted influenza vaccine e.g., live attenuated trivalentquadrivalent inactivated influenza vaccine intranasal or split trivalentquadrivalent inactivated influenza vaccine by either intradermal or intramuscular IM route within 6 months prior to randomization and up to completion of Day 21 visit. 